Point of Care Diagnostics Market Report 2026

Point of Care Diagnostics Market Overview

• Point of Care Diagnostics market size has reached to $51.62 billion in 2025 • Expected to grow to $81.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Rising Disease Prevalence Propels Growth In Point-Of-Care (POC) Diagnostics Market • Market Trend: Innovative Breakthrough Transforming Point-Of-Care Diagnostics With Quick And Accurate Results • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point of Care Diagnostics Market?

Point of care (POC) diagnostics refers to medical testing that can be performed at or near the site of patient care. It is used to provide fast and accurate results that can be used to guide immediate patient care decisions. The main product types of point of care diagnostics include glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol test strips, and others. Glucose monitoring kits refer to medical devices used to measure the levels of glucose (sugar) in a person's blood. They are prescribed based on OTC (over the counter) based devices and prescription-based devices for use by various end-users such as professional diagnostic centers, research laboratories, home care and others.

What Is The Point of Care Diagnostics Market Growth Forecast?

The point of care diagnostics market size is expected to see strong growth in the next few years. It will grow to $81.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing development of multiplex testing platforms, rising integration of digital connectivity in diagnostics, expansion of home healthcare diagnostics, growing demand for personalized medicine, increasing adoption of ai-enabled diagnostic tools. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising use of home-based testing devices, growing demand for infectious disease poc tests, expansion of otc diagnostic products, enhanced focus on real-time clinical decision making.

Global Point of Care Diagnostics Market Segmentation

1) By Product: Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Other Products 2) By Mode Of Prescription: Prescription Based Devices, OTC (Over-The-Counter) Based Devices 3) By End User: Professional Diagnostic Centers, Research Laboratories, Home Care, Other End-Users Subsegments: 1) By Glucose Monitoring Kits: Blood Glucose Meters, Test Strips 2) By Infectious Diseases Testing Kits: Rapid Antigen Tests, PCR Testing Kits, Serology Tests 3) By Pregnancy And Fertility Testing Kits: Home Pregnancy Tests, Ovulation Predictor Kits 4) By Hematology Testing Kits: Complete Blood Count (CBC) Test Kits, Coagulation Test Kits 5) By Cardiometabolic Monitoring Kits: Lipid Profile Test Kits, Blood Pressure Monitors 6) By Urinalysis Testing Kits: Dipstick Test Kits, Urine Culture Kits 7) By Cholesterol Test Strips: Home Cholesterol Testing Kits 8) By Other Products: Customizable Test Kits, Point Of Care Testing Platforms

What Is The Driver Of The Point of Care Diagnostics Market?

The increasing prevalence of chronic and infectious diseases is driving the point of care (POC) diagnostics market forward. Chronic diseases are diseases that progress slowly over time and usually last 3 months or longer. Point-of-care diagnostics is very useful in the easy management of chronic diseases and is widely used because of the convenience factor. For instance, in 2023, according to the Centers for Disease Control and Prevention (CDC), 42% of adults in the U.S. were living with two or more chronic conditions. This trend is concerning, as it highlights the growing prevalence of multiple chronic diseases among the adult population. Therefore, the increasing prevalence of chronic diseases is driving the point of care (POC) diagnostics market.

Key Players In The Global Point of Care Diagnostics Market

Major companies operating in the point of care diagnostics market are Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton Dickinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F Hoffmann La Roche Ltd, Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex Corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Biomeme Inc., Cepheid Inc.

Global Point of Care Diagnostics Market Trends and Insights

Major companies operating in the point-of-care (POC) diagnostics market are focused on developing technological innovations, such as rapid PCR systems, to gain a competitive edge in the market. A rapid PCR system is a type of polymerase chain reaction (PCR) test that can provide results in a shorter amount of time than traditional PCR tests. For instance, in January 2023, Cipla, an India-based pharmaceutical company, launched its point-of-care testing device called Cippoint. This innovative device is designed to deliver quick and accurate diagnostic results for various health conditions. The Cippoint platform is compact, user-friendly, and suitable for deployment in diverse environments such as hospitals and clinics. It employs advanced technology that enables healthcare professionals to perform tests with ease and efficiency.

What Are Latest Mergers And Acquisitions In The Point of Care Diagnostics Market?

In July 2024, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx's point-of-care technology for an undisclosed amount. This strategic move aims to enhance Roche's access to diagnostic testing in primary care settings. LumiraDx is a US-based company engaged in innovative point-of-care diagnostic solutions.

Regional Outlook

North America was the largest region in the point of care diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the point of care diagnostics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point of Care Diagnostics Market?

The point of care (POC) diagnostics market consists of sales of blood glucose meters, pregnancy test kits, and cardiac markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point of Care Diagnostics Market Report 2026?

The point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.